Triamcinolone acetonide injection for persistent atypical idiopathic orbital inflammation.
OBJECTIVE
To report a patient with atypical idiopathic orbital inflammation who was successfully treated with intra-orbital injections of triamcinolone acetonide.


METHODS
Interventional case report and literature review.


METHODS
Resolution of orbital inflammation.


RESULTS
A 71-year-old female with right orbital mass and conjunctival inflammation underwent orbital biopsy that was consistent with the diagnosis of atypical idiopathic orbital inflammation. Inflammation has deteriorated despite oral steroids. The patient underwent two additional orbital biopsies that confirmed the initial diagnosis. Intra-orbital injections of triamcinolone acetonide resulted in significant improvement and cessation of active inflammation.


CONCLUSIONS
Intra-orbital injections of triamcinolone acetonide may be an effective alternative in patients with atypical idiopathic orbital inflammation unresponsive to systemic steroids.
Skaat
Alon
A
Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel.
Rosen
Nachum
N
Rosner
Mordechai
M
Schiby
Ginette
G
Simon
Guy J Ben
GJ
D000368:Aged; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D009915:Orbit / Q000187:drug effects; D016727:Orbital Pseudotumor / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014792:Visual Acuity / Q000502:physiology
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide